| Lightning Minerals Ltd (L1M) ORDINARY FULLY PAID |
Materials |
$6 |
Ceasing to be a substantial holder
|
8 Sep 2025 8:38AM |
$0.042 |
$0.023 |
fallen by
45.24%
|
|
| Brambles Limited (BXB) ORDINARY FULLY PAID |
Industrials |
$22,273 |
Notification of cessation of securities - BXB
|
8 Sep 2025 8:38AM |
$26.560 |
$16.570 |
fallen by
37.61%
|
|
| 4DMedical Limited (4DX) ORDINARY FULLY PAID |
Health Care |
$2,362 |
4DX signs agreements with national lung screening sites
|
8 Sep 2025 8:38AM |
$1.545 |
$3.970 |
risen by
156.96%
|
|
4DX - Price-sensitive ASX Announcement
Full Release
Key Points
- 4DMedical entered agreements with Spectrum Medical Imaging and Royal Melbourne Hospital.
- The collaboration supports Australia's National Lung Cancer Screening Program (NLCSP).
- 4DMedical's software provides advanced lung function analytics using existing hardware.
- Spectrum Medical Imaging will integrate 4DMedical's tools to enhance screening quality.
- The partnership aims to improve lung disease detection and patient management.
- 4DMedical's international expansion includes a lung health screening program in Brazil.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Silver Mines Limited (SVL) ORDINARY FULLY PAID |
Materials |
$334 |
Investor Presentation
|
8 Sep 2025 8:37AM |
$0.145 |
$0.155 |
risen by
6.90%
|
|
| Amotiv Limited (AOV) ORDINARY FULLY PAID |
Consumer Discretionary |
$851 |
Update - Notification of buy-back - AOV
|
8 Sep 2025 8:36AM |
$9.800 |
$6.360 |
fallen by
35.10%
|
|
| Proteomics International Laboratories Ltd (PIQ) ORDINARY FULLY PAID |
Health Care |
$22 |
PromarkerEso precisely detects early stage esophageal cancer
|
8 Sep 2025 8:36AM |
$0.305 |
$0.135 |
fallen by
55.74%
|
|
PIQ - Price-sensitive ASX Announcement
Full Release
Key Points
- PromarkerEso blood test detects early-stage esophageal adenocarcinoma with high accuracy.
- The test is clinically validated and offers a non-invasive alternative to endoscopy.
- PromarkerEso demonstrated a minimum AUC of 0.97 in a study with 350 participants.
- The test uses four serum glycoproteins combined with clinical factors for risk assessment.
- High sensitivity for all stages of EAC and Barrett’s Esophagus with high-grade dysplasia.
- Potential to revolutionize management of esophageal cancer risk due to GERD.
- Significant commercial opportunity in the public health market.
- Proteomics International Laboratories Ltd is a leader in precision diagnostics.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Transurban Group (TCL) FULLY PAID ORDINARY/UNITS STAPLED SECURITIES |
Industrials |
$46,740 |
2025 Notice of meetings
|
8 Sep 2025 8:36AM |
$14.370 |
$14.980 |
risen by
4.24%
|
|
| First Graphene Limited (FGR) ORDINARY FULLY PAID |
Materials |
$49 |
HZR: MOU with FGR for High Value Graphite Application
|
8 Sep 2025 8:34AM |
$0.062 |
$0.056 |
fallen by
9.68%
|
|
FGR - Price-sensitive ASX Announcement
Full Release
Key Points
- Hazer Group and First Graphene signed a non-binding MOU for graphite applications.
- The collaboration focuses on assessing Hazer's graphite for First Graphene's product lines.
- The partnership addresses growing demand and supply constraints in the graphite market.
- Graphite is recognized as a critical mineral for advanced applications.
- The MOU does not create any legal obligations and further updates will follow.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Hazer Group Limited (HZR) ORDINARY FULLY PAID |
Materials |
$103 |
MOU with First Graphene for High Value Graphite Application
|
8 Sep 2025 8:34AM |
$0.350 |
$0.385 |
risen by
10%
|
|
HZR - Price-sensitive ASX Announcement
Full Release
Key Points
- Hazer Group Ltd signed a non-binding Memorandum of Understanding (MOU) with First Graphene Ltd.
- The collaboration aims to explore commercial opportunities for Hazer's graphite in First Graphene's products.
- There is a focus on assessing the technical and commercial advantages of Hazer graphite.
- Hazer's graphite marketing strategy targets both high-volume and high-value markets.
- The partnership addresses global graphite demand and supply constraints, notably those involving China.
- Hazer's graphite is recognized for its low emissions and suitability for advanced applications.
- The MOU does not create legal obligations, and further updates will be provided.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Koba Resources Limited (KOB) ORDINARY FULLY PAID |
Materials |
$9 |
Follow-Up Drill Program Underway at the Yarramba Project
|
8 Sep 2025 8:33AM |
$0.030 |
$0.033 |
risen by
10%
|
|
| Pathkey.AI Ltd (PKY) ORDINARY FULLY PAID |
Information Technology |
$25 |
Successful TrialKey Observational Predictions
|
8 Sep 2025 8:33AM |
$0.030 |
$0.041 |
risen by
36.67%
|
|
PKY - Price-sensitive ASX Announcement
Full Release
Key Points
- Pathkey.AI Ltd releases its first report on the TrialKey platform's ability to predict clinical trial outcomes successfully.
- TrialKey predicted that 8 out of 11 clinical trials (73%) would meet their primary endpoints, achieving an average hypothetical share price return of +76%.
- Highlights include significant share price increases for Abivax, Mineralys Therapeutics, and Trevi Therapeutics, among others.
- TrialKey platform analyzes over 500,000 clinical trials using AI to provide predictions.
- Observations are based on a model using probabilities of success, not actual trading.
- Pathkey.AI has a partnership with L39 Capital to apply TrialKey insights.
- TrialKey insights are also being used to optimize trial design and planning.
- All data and predictions provided by TrialKey are for informational purposes and should not be used as investment advice.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Southern Cross Gold Consolidated Ltd (SX2) CHESS DEPOSITARY INTERESTS 1:1 |
Materials |
$1,241 |
SX2 Extends High Grades to East and to Depth at Apollo East
|
8 Sep 2025 8:33AM |
$6.880 |
$9.670 |
risen by
40.55%
|
|
SX2 - Price-sensitive ASX Announcement
Full Release
Key Points
- SDDSC170A drilling intersected 3.1 meters at 41.8 g/t AuEq including 22.7 g/t Au and 8.0% Sb.
- Mineralization extended 75 meters east and 115 meters down-dip from previous limits.
- Highest antimony grade recorded at 33.7% Sb at Apollo East.
- Potential for larger tonnage mining due to broader common zones at Sunday Creek.
- Sunday Creek is a significant gold-antimony discovery with dual-metal value.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Buru Energy Limited (BRU) ORDINARY FULLY PAID |
Energy |
$17 |
Share Purchase Plan Offer Open
|
8 Sep 2025 8:32AM |
$0.019 |
$0.015 |
fallen by
23.68%
|
|
| Australian Dairy Nutritionals Group (AHF) ORDINARY FULLY PAID |
Consumer Staple |
$16 |
Change of Director's Interest Notice - Nathan
|
8 Sep 2025 8:32AM |
$0.042 |
$0.020 |
fallen by
52.38%
|
|
| Torque Metals Limited (TOR) ORDINARY FULLY PAID |
Materials |
$209 |
High-grade gold extensions at Paris Gold Project
|
8 Sep 2025 8:31AM |
$0.330 |
$0.335 |
risen by
1.52%
|
|
TOR - Price-sensitive ASX Announcement
Full Release
Key Points
- Mineral Resource Estimate at 250koz of gold at 3.1 g/t.
- Paris Gold Project positioned near major gold producers in WA.
- Project covers 57km strike length within a 350km² greenstone belt.
- Drilling indicates high-grade gold extensions beyond current resource area.
- Opportunity for further discoveries due to limited historical exploration.
- Three main deposits: Paris, HHH, and Observation, are partially tested.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Polynovo Limited (PNV) ORDINARY FULLY PAID |
Health Care |
$843 |
FY25 Annual Report
|
8 Sep 2025 8:31AM |
$1.525 |
$1.220 |
fallen by
20%
|
|
| Galileo Mining Ltd (GAL) ORDINARY FULLY PAID |
Materials |
$25 |
Significant Drill Assays Strengthen Norseman PGE Prospects
|
8 Sep 2025 8:30AM |
$0.180 |
$0.125 |
fallen by
30.56%
|
|
GAL - Price-sensitive ASX Announcement
Full Release
Key Points
- Exploration at Norseman project shows promising PGE results.
- Drilling programs focus on Callisto deposit and Mission Sill prospect.
- 10 km of anomalous PGE results along Mission Sill Eastern Contact.
- EIS funding awarded for deeper exploration at Callisto deposit.
- Callisto deposit discovered in 2022 with significant mineral resource estimate.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Flight Centre Travel Group Limited (FLT) ORDINARY FULLY PAID |
Consumer Discretionary |
$2,253 |
Update - Notification of buy-back - FLT
|
8 Sep 2025 8:29AM |
$12.380 |
$10.930 |
fallen by
11.71%
|
|
| Alice Queen Limited (AQX) ORDINARY FULLY PAID |
Materials |
$15 |
Change of Director's Interest Notice
|
8 Sep 2025 8:29AM |
$0.005 |
$0.008 |
risen by
77.78%
|
|
| Aurum Resource Limited (AUE) ORDINARY FULLY PAID |
Materials |
$232 |
Increase in MD and ED Remuneration
|
8 Sep 2025 8:29AM |
$0.600 |
$0.575 |
fallen by
4.17%
|
|
| MedAdvisor Limited (MDR) ORDINARY FULLY PAID |
Health Care |
- |
Application for quotation of securities - MDR
|
8 Sep 2025 8:29AM |
$0.046 |
$0.022 |
fallen by
52.17%
|
|
| Lowell Resources Fund (LRT) ORDINARY UNITS FULLY PAID |
Financials |
$97 |
Update - Notification of buy-back - LRT
|
8 Sep 2025 8:29AM |
$1.745 |
$2.340 |
risen by
34.10%
|
|
| Airtasker Limited (ART) ORDINARY FULLY PAID |
Communication Services |
$100 |
Application for quotation of securities - ART
|
8 Sep 2025 8:29AM |
$0.415 |
$0.205 |
fallen by
50.60%
|
|
| L1 Long Short Fund Limited (LSF) ORDINARY FULLY PAID |
Financials |
$2,846 |
Net Tangible Asset Backing
|
8 Sep 2025 8:28AM |
$3.160 |
$4.490 |
risen by
42.09%
|
|
| Janus Electric Holdings Limited (JNS) ORDINARY FULLY PAID |
Utilities |
$21 |
Janus Electric advances US Expansion with Ability Trimodal
|
8 Sep 2025 8:28AM |
$0.125 |
$0.170 |
risen by
36%
|
|
JNS - Price-sensitive ASX Announcement
Full Release
Key Points
- Janus Electric enters U.S. market with Ability Trimodal collaboration.
- Project BATTERY SWAP involves converting Class 8 trucks using battery-swapping technology.
- Partnership aims to demonstrate zero-emission freight delivery.
- Pilot operations at major California ports with real-world data collection.
- Strategic efforts focus on scalability and low-downtime operations.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.